Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angiotensin-(1-7) in COVID-19
NCT04332666Phase 3Unknown
- Sponsor
- Erasmus Hospital
- Start
- Dec 2021
- Primary completion
- Dec 2022
- Modality
- Peptides
01
Overview
Phase 3, randomised, double-blind trial of angiotensin-(1-7) in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Erasmus Hospital. Primary endpoint: Number of ventilator free days at 28 days. Status: unknown.
02
Drugs
angiotensin-(1-7)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04332666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04332666.